Citations

Clear

15 citation(s) found for "Kasprzak, J D".

Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality
Ciampi, Q C Quirino, Cortigiani, Lauro , Zagatina, Angela, Padang, Ratnasari , Kane, Garvan C, Villarraga, Hector R, Arruda‐Olson, Adelaide M. , Kalinina, Elena, Lowenstein, Jorge, Haber, Diego M Lowenstein, Marconi, Sofia, Boshchenko, Alla, Rodriguez-Zanella, Hugo, Wierzbowska-Drabik, Karina, Kasprzak, J D, Merli, Elisa , Djordjevic-Dikic, Ana, Amor, Miguel, Saad, Ariel, Safarova, Ayten, Timofeeva, T. N. , Vazquez, J P, Rigo, Fausto, Nikolic, Aleksandra, Ostojic, M, Kovacevic-Preradovic, Tamara, Cerracchio, Emma, Tripepi, Giovanni Luigi, Yin, Lixue , Villari, B, Pellikka, Patricia A, Picano, Eugenio, Zagatina, A , Ciampi, Quirino , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Ciampi, Quirino , Cortigiani, Lauro , Zagatina, Angela , Padang, Ratnasari , Villarraga, Hector R , Ryabova, Tamara , Rodriguez-Zanella, Hugo , Gaibazzi, Nicola , Pepi, Mauro , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Wang, Yi , Kane, Garvan C. , Villarraga, Hector R. , Kalinina, Elena , Lowenstein, Jorge , Arbucci, Rosina , Haber, Diego M. Lowenstein, Čelutkienė, Jelena , Boshchenko, A , Rodríguez‐Zanella, Hugo , Bursi, Francesca , Đorđević-Dikić, Ana, Amor, Miguel , Haberka, Maciej , Safarova, Ayten, Nikolic, Aleksandra, Gaibazzi, Nicola , Kovačević-Preradović, Tamara , Tripepi, Giovanni Luigi , Villari, Bruno, Carerj, Scipione , Pellikka, Patricia A. , Picano, Eugenio

Mayo Clinic

ESC Heart Failure | May 23, 2026 | Volume: 13 | Issue: 4 | Pages: No page available

10.1093/eschf/xvag151 | PMID 42249823 Get It

Abstract Introduction Transthoracic echocardiography (TTE) identifies a hypercontractile phenotype (HP) in chronic coronary syndromes (CCS), characterized by elevated resting left ventricular (LV) elastance (force = systolic blood pressure/end-systolic volume). To evaluate the prognostic significance and functional correlates of HP. Methods In a prospective multicentre study, 10 677 patients with CCS underwent resting TTE to assess LV ejection fraction (EF), stroke volume, and force by quantitative volumetric echocardiography. All patients were followed for the endpoint of all-cause mortality. In a subset of 5834 patients, stress echocardiography (exercise or dobutamine) was performed for LV contractile reserve and heart rate reserve. Results Patients were stratified into Force quintiles (Q1–Q5). Patients with hypercontractile phenotype exhibited lower stroke volume at rest (Q5 = 34.8 ± 12.3 vs Q1–Q4 = 57.4 ± 19.1 mL; P < .01) and higher EF at rest (Q5 = 64.8 ± 6.9% vs Q1–Q4 = 58.1 ± 8.7%, P < .01). During a median follow-up of 24 months (interquartile range = 12–40 months), 509 deaths occurred. The exposure-adjusted death rate was lowest in Q3 (3.53–4.51 mmHg/mL; 1.03 per 100 person/years) and higher in Q1 (≤2.62 mmHg/mL, 2.88), Q2 (2.63–3.52 mmHg/mL, 1.86), Q4 (4.52–6.11 mmHg/mL, 1.56), and Q5 (HP, >6.11 mmHg/mL; 1.88; P < .0001 vs Q1 and Q3). Multivariable analysis identified HP (Q5; HR 1.531 vs Q3, 95% CI 1.116–2.099; P = .006) and EF (HR 0.963, 95% CI 0.953–0.972; P < .0001) as independent predictors of death. During exercise or dobutamine stress, HP showed reduced LV contractile reserve (ΔEF: Q5 = 4.3 ± 9.4% vs Q1–Q4 = 7.0 ± 9.3%; P < .001) and blunted heart rate reserve (Q5 = 1.77 ± 0.33 vs Q1–Q4 = 1.85 ± 0.39; P < .01). All patients with force-based LV contractile reserve >4.1 (present in 185, 3.2% of the population) survived. Conclusion Patients with CCS with HP assessed by resting TTE demonstrate higher mortality and multilayered functional impairment, including reduced LV contractile and chronotropic reserves. Hypercontractile phenotype improved the prediction of mortality by EF. A ‘stronger’ heart is, in fact, functionally and prognostically weaker.
Prognostic value of coronary flow velocity reserve in obese patients with preserved ejection fraction and negative stress echocardiography
Ciampi, Chirino, Barbieri, A, Haberka, M, Arbucci, R, Zagatina, A, Wierzbowska-Drabik, K, Kasprzak, J D, Rodriguez-Zanella, H R Hugo, Djordjevic-Dikic, A, Celutkiene, J D, Merli, Elisa , Pellikka, P A, Picano, E, Mantovani, Francesca , Ciampi, Quirino , Haberka, Maciej , Arbucci, Rosina , Zagatina, A, Wierzbowska-Drabik, K, Kasprzak, J D, Rodríguez‐Zanella, Hugo , Boshchenko, A , Djordjevic-Dikic, A, Čelutkienė, Jelena , Pellikka, Patricia A. , Picano, Eugenio

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.111 Get It

Abstract Background Obese patients often exhibit a clustering of cardiovascular risk factors and are frequently referred for noninvasive cardiac imaging. Coronary microvascular dysfunction (CMD) represents an early indicator of cardiovascular disease that can be noninvasively diagnosed using coronary flow velocity reserve (CFVR) measurements obtained during stress echocardiography (SE) in patients without evidence of obstructive coronary artery disease (CAD). Purpose This study aimed to evaluate the prognostic significance of CFVR in overweight and obese patients within a prospective multicenter cohort. Methods 2273 patients (mean age 65 ± 11 years; 51% women) classified as overweight or obese (for definition see Table) were included in 27 sites from 11 countries. All patients had normal left ventricular ejection fraction (EF ≥ 50%), no prior history of CAD, and underwent exercise or pharmacological SE, which was negative for inducible ischemia. CFVR of the left anterior descending coronary artery was assessed, with CMD defined as CFVR >2.0. Patients were divided into two groups based on the presence (Group 1) or absence (Group 2) of CMD. The primary endpoint was overall mortality. Results CMD was identified in 492 patients (22%), with a mean CFVR of 2.3 ± 0.5 across the study population. Group 1 patients (CMD) were older, with a greater prevalence of diabetes and metabolic syndrome compared to group 2 (no CMD) (Table). During a median follow-up period of 2.1 years (IQR: 1.2-3.7 years), 103 patients (5%) died. Patients with CMD had significantly worse late survival compared to those without CMD (3-year survival: 96 ± 1% vs. 96 ± 1%, p=ns; 6-year survival: 79 ± 4% vs. 93 ± 1%, p < 0.0001): see Figure. Multivariate analysis adjusting for age, sex, EF, body mass index, smoking habits, diabetes, dyslipidemia, arterial hypertension, and type of stress confirmed CMD as an independent predictor of mortality (hazard ratio: 1.8 [95% CI: 1.1–2.8], p = 0.01). Conclusions CMD, assessed via CFVR during SE, was a robust and independent prognostic marker of long-term mortality in obese patients with preserved EF and no evidence of inducible ischemia. These findings underscore the pivotal role of noninvasive assessment of CMD in refining risk stratification and guiding clinical decision-making in this high-risk population.
Survival prediction by comprehensive stress echocardiography
Cortigiani, L, Arbucci, R, Mosto, Hugo , Djordjevic‐Dikic, Ana , Picano, Eugenio , Ciampi, Quirino , Cortigiani, L, Zagatina, A , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Lowenstein, Jorge , Boshchenko, A , Čelutkienė, Jelena , Haberka, Maciej , Rodríguez‐Zanella, Hugo , Pellikka, Patricia A.

Mayo Clinic

European Heart Journal | November 8, 2025 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.105 Get It

Abstract Background Stress echocardiography (SE) was recently upgraded to the ABCDE protocol: step A, regional wall motion abnormalities; step B, B-lines; step C, left ventricular contractile reserve; step D, Doppler-based coronary flow velocity reserve in left anterior descending coronary artery; and step E, EKG-based heart rate reserve. Aim to assess the prognostic value of ABCDE-SE in a prospective, large-scale, multicenter, international, effectiveness study. Methods From July 2016 to November 2024, we enrolled 7896 all-comers (age 65±11 years, 4742 [60.0%] males, ejection fraction 59±10%) with known or suspected chronic coronary syndromes (CCS) referred from 27 certified laboratories. All patients underwent clinically indicated ABCDE-SE, with ACE in all patients, step D in 6286, step B in 5951 and all 5 steps in 5918 pts. The employed stress modality was exercise (n=2407) or pharmacological stress (n=5489; with vasodilator, n=4503; or dobutamine, n=986). Each step was scored from 0 (normal) to 3 (severely abnormal) following EACVI recommendations 2024. SE response ranged from a score of 0 (all steps normal) to a score of 15 (all steps severely abnormal). All-cause death was the only end-point. Results During a median follow-up of 685 days (interquartile range: 387-1227), 370 deaths occurred. Step A negativity was associated with a 1.5% annual mortality. Annual mortality rate ranged from 0.4% persons/year for score 0 (n=958, 12.1%) up to 6.19% person/year for score ≥10 (n=346, 4.3%). (Figure). At multivariate logistic regression analysis, age (hazard ratio [HR] 1.008, 95% interquartile range [IQ]: 1.006-1.010, p<0.001), diabetes (HR 1.564, 95% CI: 1.263-1.936, p<0.001), resting ejection fraction (HR 0.983, 95% CI: 0.974-0.993, p=0.001), and ABCDE score 3-5 (HR 3.111, 95% CI 1.597-6.060, p=0.001), score 6-9 (HR 5.442, 95% CI 2.761-10.729, p<0.001), and score ≥10 (HR 8.826, CI 4.197-18.654, p<0.001) were independent predictors of mortality. Conclusion In patients with known or suspected CCS, SE negativity by simple wall motion criterion is unable to identify a low-risk group. ABCDE-SE allows an effective prediction of survival.Figure
Chronotropic incompetence during exercise or pharmacological stress is associated with reduced survival in patients with chronic coronary syndromes
Cortigiani, Lauro , Zagatina, A , Padang, Ratnasari , Kane, Garvan C. , Villarraga, Hector R. , Arruda‐Olson, Adelaide M. , Gaibazzi, Nicola , Wierzbowska‐Drabik, Karina , Boshchenko, A , Журавлева, О. А. , Sviazova, Natalia , Amor, Miguel , Kasprzak, Jarosław D. , Merli, Elisa , Vazquez, Jesus Peteiro , Rigo, Fausto , Djordjevic‐Dikic, Ana , Haber, Diego M. Lowenstein, Bovenzi, Francesco, Bartolacelli, Ylenia , Tripepi, Giovanni Luigi, Picano, Eugenio , Zagatina, Angela , Padang, Ratnasari , Gaibazzi, Nicola , Donelli, Davide , Rodriguez-Zanella, Hugo , Pepi, Mauro , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Boshchenko, Alla , Ciampi, Quirino , Kalinina, Elena , Arbucci, Rosina , Čelutkienė, Jelena , Haberka, Maciej , Rodríguez‐Zanella, Hugo , Varga, Albert , Saad, Ariel K. , Lowenstein, Jorge , Carerj, Scipione , Pellikka, Patricia A.

Mayo Clinic

European Journal of Preventive Cardiology | September 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/eurjpc/zwaf492 | PMID 40908497 Get It

Abstract Aims Chronotropic incompetence (CI) is a biomarker of cardiac autonomic dysfunction. The aim of the study is to assess the risk stratification value of CI during exercise or pharmacological stress echocardiography in patients with chronic coronary syndromes. Methods and results In a prospective, multicenter, international, observational study, we enrolled 13 445 patients with known or suspected chronic coronary syndromes who underwent stress echocardiography in 19 clinical sites from 10 countries using either exercise (n = 2594), dobutamine (n = 2440), or dipyridamole (n = 8411). Heart rate was automatically measured from the 1-lead ECG in the echocardiography monitor. We considered CI as failure to reach 85% of the maximal predicted (220-age) heart rate for exercise and dobutamine, and heart rate reserve (peak/rest heart rate) ≤ 1.22 (≤1.17 if in permanent atrial fibrillation) for dipyridamole stress. The primary outcome was all-cause death. CI was observed in 5045 patients (38%) and stress-induced regional wall motion abnormalities in 1648 (13%). Over a median follow-up time of 3.4 years (interquartile range, 1.6–9.1 years), there were 2426 (18%) deaths. The 10-year mortality was 39% in patients with and 21% in patients without CI (P < 0.0001). CI was associated with a significant increase in 10-year mortality in all age groups ranging from ≤54 years to ≥75 years (P < 0.0001). In addition, it was associated with increased mortality (P < 0.0001) irrespective of β-blocker use. Cox multivariable analysis revealed that CI was an independent predictor of mortality (HR: 1.60, 95% confidence interval: 1.47–1.74; P < 0.0001) together with age, male sex, diabetes mellitus, left ventricular ejection fraction, and resting heart rate. Conclusion In patients with chronic coronary syndromes, CI during exercise or pharmacological stress is a simple and objective predictor of survival.
Stress Echo 2030 Study: A Flagship Project of the Italian Society of Echocardiography and Cardiovascular Imaging
Picano, Eugenio, Padang, Ratnasari , Kane, Garvan C. , Villarraga, Hector R. , Arruda‐Olson, Adelaide M. , Vazquez, Jesus Peteiro , Boshchenko, A , Журавлева, О. А. , Sviazova, Natalia , Balkevičienė, Laura, Djordjevic‐Dikic, Ana , Kobal, Sergio , Lisi, Matteo , Merli, Elisa , Manganelli, F, Daros, Clarissa Borguezan , D’Alfonso, Maria Grazia , Mori, Fabio , Kasprzak, Jarosław D. , Safarova, Ayten, Timofeeva, T. N. , Mosto, Hugo , Wierzbowska‐Drabik, Karina , Ratanasit, Nithima , Colonna, Paolo , Ostojić, Miodrag , Cortigiani, Lauro , Rigo, Fausto , Benfari, Giovanni , Soulis, Dimitrios , Yin, Lixue , Mazzi, Alberto, Haber, Diego M. Lowenstein, Marconi, Sofia, Tripepi, Giovanni Luigi, Nes, Michele De, Bartolacelli, Ylenia , Villari, Bruno, Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Benfari, Giovanni , Colonna, Paolo , Boshchenko, Alla , Ciampi, Quirino , Arbucci, Rosina , Zagatina, A , Kalinina, Elena , Ryabova, Tamara , Čelutkienė, Jelena , Saad, Ariel K. , Bursi, Francesca , Rodríguez‐Zanella, Hugo , Gaibazzi, Nicola , Costantino, Marco Fabio , Kovačević-Preradović, Tamara , Varga, Albert , Nikolic, Aleksandra, Cocchia, Rosangela , Pálinkás, Attila , Pálinkás, Eszter Dalma , Valente, Filipa Xavier , Wang, Yi , Heyning, Caroline M. Van De , Mazzi, Alberto, Lowenstein, Jorge , Barbieri, Andréa , Mantovani, Francesca , Pepi, Mauro , Carerj, Scipione , Pellikka, Patricia A.

Mayo Clinic

Journal of Cardiovascular Echography | May 1, 2025 | Volume: 35 | Issue: 1 | Pages: 1-7

10.4103/jcecho.jcecho_2_25 | PMID 40463758 Get It

Over the past decade, stress echocardiography has evolved from a test for assessing epicardial artery stenosis to a comprehensive functional test, targeting multiple cardiovascular parameters. The new approach includes several structured steps: (a) evaluating regional wall motion abnormalities to detect epicardial artery stenosis or vasospasm; (b) assessing pulmonary congestion and diastolic function via B-lines with lung ultrasound; (c) gauging preload and contractile reserve with volumetric echocardiography; (d) measuring coronary microvascular reserve using Doppler-based coronary flow velocity in the middistal left anterior descending artery; and (e) determining cardiac sympathetic reserve by tracking heart rate reserve on an ECG. This evolution was supported extensively by the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI), which played a key role in five areas: (1) developing the initial, curiosity-driven project; (2) disseminating protocols and results at national and international conferences, supporting logistic infrastructure and publication expenses; (3) establishing a digital platform (customized Redcap) for data entry and storage; (4) facilitating patient recruitment across 19 Italian centers; and (5) offering formal endorsement through six presidencies, adding credibility and reach beyond any single institution. The protocol quickly advanced from concept to high-impact publications, earning inclusion in 2024 specialty guidelines. Initially Italian-led, the study now includes 50 centers across 20 countries (e.g. USA and China). Beyond the 50 peer-reviewed papers published in 2016–2024, this study offers a novel, sustainable approach to cardiac stress testing, providing more information at lower costs, with zero radiation and minimal environmental impact. SIECVI’s endorsement was instrumental in amplifying the study’s rigor and outreach.
Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes
Wang, Y, Cerracchio, Emma, Cortigiani, L, Zagatina, A, Kasprzak, J D, Wierzbowska-Drabik, K, Boshchenko, A , Djordjevic‐Dikic, Ana , Pitino, Annalisa , Tripepi, Giovanni Luigi, Citro, R, Picano, Eugenio , Boshchenko, Alla , Ciampi, Quirino , Cortigiani, L, Zagatina, A, Gaibazzi, Nicola , Pellikka, Patricia A.

Mayo Clinic

European Heart Journal | October 28, 2024 | Volume: 45 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehae666.105 Get It

Abstract Background Hypercontractile phenotype of the left ventricle (LV) is an actionable therapeutic target in patients with chronic coronary syndromes (CCS), but its clinical recognition remains elusive. Purpose To assess the clinical variables associated with the hypercontractile phenotype of the LV, identified with supernormal values of an index of LV contractility such as LV force, also known as ventricular elastance. Methods In a prospective, observational, multicenter study, we recruited 5,122 patients (age 65± 11.1 years, 2974 males, 58%) with CCS referred for resting transthoracic echocardiography with technically successful volumetric echocardiography in 17 accredited laboratories. We measured systolic blood pressure (SBP) with a cuff sphygmomanometer. We assessed semi-quantitatively wall motion score index (WMSI), and quantitatively LV end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), force (SBP/ESV), stroke volume (SV), arterial elastance (SBP/SV), ventricular-arterial coupling (VAC, as SV/ESV), and cardiac output (CO = SV*heart rate).Univariable and multivariable logistic regression analysis assessed independent factors associated with the highest force sextile. Odds ratios (ORs) with the corresponding 95% confidence interval (CI) were estimated. Results For all the studied patients, EF was 59±11%. Force was 4.51±2.11 mmHg/ml, with reference sextile = 3.50-4.26 mmHg/ml, lowest sextile (Group 1) <2.60 mmHg/ml and highest sextile (Group 6) > 6.36 mmHg/ml. The correlation between the log of EF and the log of Force was significant with linear regression (r = 0.73, p < 0.001). Patients in the highest sextile of force showed lower values of WMSI, SV, EDV, and ESV, and higher values of arterial elastance and VAC (Table). By multivariable logistic regression model, the highest sextile of force was associated with age > 71 years (OR 4.35, 95% CI 3.06-6.18, p < 0.001), female sex (OR 4.48, 95% CI 3.62-5.54, p < 0.001), absence of beta-blocker therapy (OR 1.56, 95% CI 1.27-1.91), rest SBP> 159 mmHg (OR 6.86, 95% CI 5.03-9.35, p < 0.001), high heart rate (OR 1.03, 95% CI 1.02-1.04, p < 0.001), absence of prior MI (OR 1.31, 95% CI 1-1.72, p = 0.049), and higher LV EF at rest (OR 1.24, 95% CI 1.22-1.26, p < 0.001). Conclusions A hypercontractile phenotype of the LV with high force is associated with a small heart, reduced SV, and higher arterial elastance. It was clinically associated with advanced age, female sex, history of hypertension, absence of beta-blocker therapy, and high resting SBP.
Reduced stroke volume by resting 2-dimensional echocardiography negatively affects survival in patients with abnormal ejection fraction
Cortigiani, L, Kasprzak, J D, Wierzbowska-Drabik, K, Djordjevic-Dikic, A, Rigo, F , Pitino, Annalisa , Tripepi, Giovanni, Villari, Bruno, Picano, Eugenio , Ciampi, Quirino , Cortigiani, L, Zagatina, A , Haberka, Maciej , Gaibazzi, Nicola , Rodríguez‐Zanella, Hugo , Pellikka, Patricia A.

Mayo Clinic

European Heart Journal | October 28, 2024 | Volume: 45 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehae666.106 Get It

Abstract Background Abnormal (<50%) ejection fraction (EF) is a cornerstone of risk stratification and therapy, but also an imperfect proxy of left ventricular (LV) cardiac pump function, better assessed with stroke volume (SV). Aim To assess the value of SV in stratifying risk of patients with abnormal EF. Methods In a prospective, observational, multicenter study, we recruited 746 patients (age 66± 11 years, 536 males, 72%, 359 with previous myocardial infarction, 48%) with chronic coronary syndromes (CCS) and EF <50% referred for resting transthoracic echocardiography with technically successful 2-dimensional volumetric echocardiography in 17 accredited laboratories. We quantitatively assessed LV end-diastolic volume (EDV) and end-systolic volume (ESV) by Simpson’s biplane method. EF (EDV-ESV/EDV) and SV (EDV-ESV) were calculated from LV volumes. The outcome end-point was all-cause death. Results EF was 39±9%, SV 48±20 ml. There were 100 all-cause deaths during a median follow-up of 796 days (interquartile range 420-1286 days). Receiver-operating curve analysis identified SV≤31.4 ml/b as the best cut-off for predicting mortality. At multivariable analysis, after adjustment for age and prior myocardial infarction, EF <40% and SV ≤31.4 ml/b were significantly associated with decreased survival (HR 2.09, 95%, confidence intervals 1.09-4.01, p=0.024). The annual mortality was lowest (3.19%) in the group with mildly reduced (40-49%) EF and normal (>31.4 ml) SV, and highest (8.30%) in patients with both reduced EF and abnormal SV: see figure. Conclusion Patients with CCS and abnormal EF are a prognostically heterogeneous group, and the mortality rate is almost 3-times worse in patients with reduced EF and abnormal SV compared to patients with mildly reduced EF and normal SV. A simple resting volumetric two-dimensional echocardiography can offer an efficient risk stratification, beyond EF, with no extra imaging or analysis time.Figure
Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes or heart failure
Cortigiani, Lauro , Souto, Germán, Djordjevic‐Dikic, Ana , Reisenhofer, Barbara, Boshchenko, A , Rigo, F , Merli, Elisa , Lisi, Matteo , Simova, Iana , Pitino, Annalisa , Nes, Michele De, Tripepi, Giovanni Luigi, Yin, Lixue , Picano, Eugenio , Boshchenko, Alla , Wang, Yi , Ciampi, Quirino , Zagatina, A , Kasprzak, Jarosław D. , Wierzbowska‐Drabik, Karina , Haberka, Maciej , Lowenstein, Jorge , Arbucci, Rosina , Haber, Diego M. Lowenstein, Marconi, Sofia, Merlo, Pablo , Barral, Patricia, Ryabova, Tamara , Rodríguez‐Zanella, Hugo , D’Andrea, Antonello , Gaibazzi, Nicola , Barbieri, Andréa , Morrone, Doralisa , Citro, Rodolfo , Carerj, Scipione , Pepi, Mauro , Pellikka, Patricia A. , group, on behalf of the Stress Echo 2030 study

Mayo Clinic

No container title available | June 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4476811/v1 Get It

Abstract Background Hypercontractile phenotype (HP) of the left ventricle (LV) is an actionable therapeutic target in patients with chronic coronary syndromes (CCS) or heart failure (HF), but its clinical recognition remains difficult. Objectives To assess the clinical variables associated with the HP. Methods In a prospective, observational, multicenter study, we recruited 5,122 patients (age 65 ± 11 years, 2974 males, 58%) with CCS and/or HF with preserved ejection fraction (EF). Systolic blood pressure (SBP) was measured. We assessed wall motion score index (WMSI), LV end-diastolic volume (EDV), end-systolic volume (ESV), EF, force (SBP/ESV), stroke volume (SV), arterial elastance (SBP/SV), and ventricular-arterial coupling (VAC, as SV/ESV). Univariable and multivariable logistic regression analysis assessed independent factors associated with the highest force sextile. Results For all the studied patients, force was 4.51 ± 2.11 mmHg/ml, with the highest sextile (Group 6) > 6.36 mmHg/ml. By multivariable logistic regression model, the highest sextile of force was associated with age > 65 years (OR 1.62, 95% CI 1.36–1.93, p < 0.001), hypertension (OR 1.76, 95% CI 1.40–2.21, p < 0.001), female sex (OR 4.52, 95% CI 3.77–5.42, p < 0.001), absence of beta-blocker therapy (OR 1.41, 95% CI 1.16–1.68), rest SBP ≥ 160 mmHg (OR 2.81, 95% CI 2.21–3.56, p < 0.001), high heart rate (OR 2.08, 95% CI 1.61–2.67, p < 0.001), and absence of prior myocardial infarction (OR 1.34, 95% CI 1.07–1.68, p = 0.012). Patients in the highest sextile of force showed lower values of WMSI, SV, EDV, and ESV, and higher values of arterial elastance and VAC. Conclusions HP of the LV with high force was clinically associated with advanced age, female sex, high resting SBP, and the absence of 𝛽-blocker therapy. By transthoracic echocardiography, HP was associated with a small heart with reduced EDV, reduced SV despite high EF, and higher arterial elastance.
High Resting Coronary Flow Velocity by Echocardiography Is Associated With Worse Survival in Patients With Chronic Coronary Syndromes
Cortigiani, Lauro , Gaibazzi, Nicola , Ciampi, Quirino , Rigo, F , Rodríguez‐Zanella, Hugo , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Arbucci, Rosina , Lowenstein, Jorge , Zagatina, A , Bartolacelli, Ylenia , Picano, Eugenio , group, the Stress Echo 2030 study, Rigo, Fausto , Zagatina, Angela , Gregori, Dario , Carerj, Scipione , Pepi, Mauro , Pellikka, Patricia A , Picano, Eugenio , Ciampi, Quirino , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Gaibazzi, Nicola , Arbucci, Rosina , Rodriguez-Zanella, Hugo , Pellikka, Patricia A. , group, the Stress Echo 2030 study

Mayo Clinic

Journal of the American Heart Association | February 16, 2024 | Volume: 13 | Issue: 4 | Pages: No page available

10.1161/jaha.123.031270 | PMID 38362899 Get It

Background Resting coronary flow velocity (CFV) in the mid‐distal left anterior descending coronary artery can be easily assessed with transthoracic echocardiography. In this observational study, the authors sought to assess the relationship between resting CFV, CFV reserve (CFVR), and outcome in patients with chronic coronary syndromes. Methods and Results In a prospective multicenter study design, the authors retrospectively analyzed 7576 patients (age, 66±11 years; 4312 men) with chronic coronary syndromes and left ventricular ejection fraction ≥50% referred for dipyridamole stress echocardiography. Recruitment (years 2003–2021) involved 7 accredited laboratories, with interobserver variability <10% for CFV measurement at study entry. Baseline peak diastolic CFV was obtained by pulsed‐wave Doppler in the mid‐distal left anterior descending coronary artery. CFVR (abnormal value ≤2.0) was assessed with dipyridamole. All‐cause death was the only end point. The mean CFV of the left anterior descending coronary artery was 31±12 cm/s. The mean CFVR was 2.32±0.60. During a median follow‐up of 5.9±4.3 years, 1121 (15%) patients died. At multivariable analysis, resting CFV ≥32 cm/s was identified by a receiver operating curve as the best cutoff and was independently associated with mortality (hazard ratio [HR], 1.24 [95% CI, 1.10–1.40]; P <0.0001) together with CFVR ≤2.0 (HR, 1.78 [95% CI, 1.57–2.02]; P <0.0001), age, diabetes, history of coronary surgery, and left ventricular ejection fraction. When both CFV and CFVR were considered, the mortality rate was highest in patients with resting CFV ≥32 cm/s and CFVR ≤2.0 and lowest in patients with resting CFV <32 cm/s and CFVR >2.0. Conclusions High resting CFV is associated with worse survival in patients with chronic coronary syndromes and left ventricular ejection fraction ≥50%. The value is independent and additive to CFVR. The combination of high resting CFV and low CFVR is associated with the worst survival.